Search Results - "Yamamoto, Kuniharu"

Refine Results
  1. 1
  2. 2

    Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer by Shibata, Chikashi, Nakano, Toru, Yasumoto, Akihiro, Mitamura, Atsushi, Sawada, Kentaro, Ogawa, Hitoshi, Miura, Tomoya, Ise, Ichiro, Takami, Kazuhiro, Yamamoto, Kuniharu, Katayose, Yu

    Published in BMC surgery (03-06-2022)
    “…Our aim of was to compare importance of the tumor markers (TMs) serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 in prediction of…”
    Get full text
    Journal Article
  3. 3

    Major hepatectomy for perihilar cholangiocarcinoma by Unno, Michiaki, Katayose, Yu, Rikiyama, Toshiki, Yoshida, Hiroshi, Yamamoto, Kuniharu, Morikawa, Takanori, Hayashi, Hiroki, Motoi, Fuyuhiko, Egawa, Shinichi

    “…Background/purpose Hilar cholangiocarcinoma and intrahepatic cholangiocarcinoma involving the hepatic hilus are defined as “perihilar cholangiocarcinoma”. The…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Biliary Schwannoma That Required Differentiation from Bile Duct Cancer by Takami, Kazuhiro, Yamamoto, Kuniharu, Sakurai, Hiroto, Kondo, Noriko, Shibata, Chikashi, Katayose, Yu

    Published in Case reports in gastroenterology (30-06-2021)
    “…Schwannomas are benign tumors originating from Schwann cells, which are the main component of the neural sheath. Biliary schwannomas are extremely rare. We…”
    Get full text
    Journal Article
  8. 8

    Influence of age on postoperative complications especially pneumonia after gastrectomy for gastric cancer by Shibata, Chikashi, Ogawa, Hitoshi, Nakano, Toru, Koyama, Kaori, Yamamoto, Kuniharu, Nagao, Munenori, Takeyama, Daisuke, Takami, Kazuhiro, Yasumoto, Akihiro, Sase, Tomohiko, Kimura, Shun-Ichi, Sawada, Kentaro, Katayose, Yu

    Published in BMC surgery (08-08-2019)
    “…The aim of this study was to investigate the influence of patients' age on postoperative morbidities including pneumonia. We reviewed the clinical records of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    The preclinical development of regorafenib for the treatment of colorectal cancer by Miura, Koh, Satoh, Masayuki, Kinouchi, Makoto, Yamamoto, Kuniharu, Hasegawa, Yasuhiro, Philchenkov, Alex, Kakugawa, Yoichiro, Fujiya, Tsuneaki

    Published in Expert opinion on drug discovery (01-09-2014)
    “…The RAS-RAF-MEK-ERK pathway is one of the best characterized kinase cascades. During the exploration of small molecules that inhibit RAF1 kinase, regorafenib…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    The use of natural products in colorectal cancer drug discovery by Miura, Koh, Satoh, Masayuki, Kinouchi, Makoto, Yamamoto, Kuniharu, Hasegawa, Yasuhiro, Kakugawa, Yoichiro, Kawai, Masaaki, Uchimi, Kiyoshi, Aizawa, Hiroki, Ohnuma, Shinobu, Kajiwara, Taiki, Sakurai, Hiroto, Fujiya, Tsuneaki

    Published in Expert opinion on drug discovery (01-04-2015)
    “…Natural products (NPs) are evolutionarily designed and contain more complex and challenging structures than synthetic compounds. Since the 1980s, the…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    ZD1839 (IRESSA®) Stabilizes p27Kip1 and Enhances Radiosensitivity in Cholangiocarcinoma Cell Lines by YABUUCHI, Shinichi, KATAYOSE, Yu, YOSHIDA, Hiroshi, OHTUSKA, Hideo, MOTOI, Fuyuhiko, EGAWA, Shinichi, UNNO, Michiaki, ODA, Akira, MIZUMA, Masamichi, SHIRASOU, Satoru, SASAKI, Tsuyoshi, YAMAMOTO, Kuniharu, OIKAWA, Masaya, RIKIYAMA, Toshiki, ONOGAWA, Tohru

    Published in Anticancer research (01-04-2009)
    “…The prognosis of cholangiocarcinoma patients is extremely poor despite the aggressive multidisciplinary cancer therapies that have been used clinically ( 1 )…”
    Get full text
    Journal Article
  19. 19

    Severe cholestatic liver failure associated with gemcitabine adjuvant monotherapy for pancreatic cancer by Okada, Takaho, Egawa, Shinichi, Motoi, Fuyuhiko, Yamamoto, Kuniharu, Ottomo, Shigeru, Sakata, Naoaki, Rikiyama, Toshiki, Katayose, Yu, Unno, Michiaki

    Published in Clinical journal of gastroenterology (01-12-2011)
    “…We report a case of severe hepatic failure caused by gemcitabine hydrochloride (GEM) monotherapy after pancreaticoduodenectomy for advanced pancreatic cancer…”
    Get full text
    Journal Article
  20. 20

    Up-regulated p27Kip1 Reduces Matrix Metalloproteinase-9 and Inhibits Invasion of Human Breast Cancer Cells by MIZUMA, Masamichi, KATAYOSE, Yu, OHTSUKA, Hideo, MOTOI, Fuyuhiko, EGAWA, Shinichi, UNNO, Michiaki, YAMAMOTO, Kuniharu, SHIRASO, Satoru, SASAKI, Tsuyoshi, YABUUCHI, Shinichi, ODA, Akira, MASUDA, Kunihiro, RIKIYAMA, Toshiki, ONOGAWA, Tohru

    Published in Anticancer research (01-09-2008)
    “…Background: p27 Kip1 is a cyclin-dependent kinase inhibitor which has been reported to be associated with invasion, metastasis and angiogenesis in malignant…”
    Get full text
    Journal Article